Nicolas Sitchon
Director Ejecutivo en S1 BioPharma, Inc. .
Perfil
Nicolas Gomez Sitchon is currently the Chairman, President & Chief Executive Officer at S1 BioPharma, Inc. He has been in this position since 2010.
He has a graduate degree from Boston University School of Medicine and an MBA from Questrom School of Business.
Cargos activos de Nicolas Sitchon
| Empresas | Cargo | Inicio |
|---|---|---|
S1 BioPharma, Inc.
 S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Director Ejecutivo | 01/10/2010 |
Formación de Nicolas Sitchon.
| Boston University School of Medicine | Graduate Degree |
| Questrom School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
S1 BioPharma, Inc.
S1 BioPharma, Inc. Pharmaceuticals: MajorHealth Technology S1 BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drugs for the treatment of sexual dysfunction in both women and men. Its product portfolio include Lorexy's, Orexa, S1B-307, and S1B-3006. The company was founded in 2008 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Nicolas Sitchon
